Differential In Vitro Growth and Cell Killing of Cancer versus Benign Prostate Cells by Oncolytic Parainfluenza Virus

The development of effective oncolytic viruses will require understanding the differences in virus replication and killing between normal and cancer cells. Here, we have evaluated infections of metastatic cancer (22Rv1) and benign non-tumorigenic (BPH-1) prostate cell lines with a mutant parainfluen...

Full description

Bibliographic Details
Main Authors: Kritika Kedarinath, Griffith D. Parks
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/11/5/493
_version_ 1797497086981177344
author Kritika Kedarinath
Griffith D. Parks
author_facet Kritika Kedarinath
Griffith D. Parks
author_sort Kritika Kedarinath
collection DOAJ
description The development of effective oncolytic viruses will require understanding the differences in virus replication and killing between normal and cancer cells. Here, we have evaluated infections of metastatic cancer (22Rv1) and benign non-tumorigenic (BPH-1) prostate cell lines with a mutant parainfluenza virus 5 (P/V/F) encoding a defective V protein and a hyperfusogenic F protein. Under low multiplicity of infection (MOI), the P/V/F mutant efficiently spread in 22Rv1 cells but was restricted in BPH-1 cells due to type-I interferon (IFN-I) responses. In mixed co-cultures, the P/V/F mutant showed specificity towards and spread within the 22Rv1 cells versus BPH-1 cells. Under high MOI conditions, both BPH-1 and 22Rv1 cells showed efficient infection by the P/V/F mutant. However, compared to BPH-1 cells, the 22Rv1 cancer cells showed increased cytopathic effect, higher induction of caspase-8 and -9, and extensive syncytia formation. In 22Rv1 spheroid cultures, P/V/F infection was less efficient compared to monolayers, but the virus was able to spread through spheroids and induce death. These data indicate that IFN-I sensitivity is a major determinant of specificity of P/V/F spread through populations of cancer versus benign cells, and additionally, differences in activation of apoptotic pathways and syncytia formation can contribute to differential outcomes in cancer versus benign cells.
first_indexed 2024-03-10T03:12:28Z
format Article
id doaj.art-869162697e0547dd9a790c1351e3147e
institution Directory Open Access Journal
issn 2076-0817
language English
last_indexed 2024-03-10T03:12:28Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj.art-869162697e0547dd9a790c1351e3147e2023-11-23T12:31:28ZengMDPI AGPathogens2076-08172022-04-0111549310.3390/pathogens11050493Differential In Vitro Growth and Cell Killing of Cancer versus Benign Prostate Cells by Oncolytic Parainfluenza VirusKritika Kedarinath0Griffith D. Parks1Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL 32827, USABurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL 32827, USAThe development of effective oncolytic viruses will require understanding the differences in virus replication and killing between normal and cancer cells. Here, we have evaluated infections of metastatic cancer (22Rv1) and benign non-tumorigenic (BPH-1) prostate cell lines with a mutant parainfluenza virus 5 (P/V/F) encoding a defective V protein and a hyperfusogenic F protein. Under low multiplicity of infection (MOI), the P/V/F mutant efficiently spread in 22Rv1 cells but was restricted in BPH-1 cells due to type-I interferon (IFN-I) responses. In mixed co-cultures, the P/V/F mutant showed specificity towards and spread within the 22Rv1 cells versus BPH-1 cells. Under high MOI conditions, both BPH-1 and 22Rv1 cells showed efficient infection by the P/V/F mutant. However, compared to BPH-1 cells, the 22Rv1 cancer cells showed increased cytopathic effect, higher induction of caspase-8 and -9, and extensive syncytia formation. In 22Rv1 spheroid cultures, P/V/F infection was less efficient compared to monolayers, but the virus was able to spread through spheroids and induce death. These data indicate that IFN-I sensitivity is a major determinant of specificity of P/V/F spread through populations of cancer versus benign cells, and additionally, differences in activation of apoptotic pathways and syncytia formation can contribute to differential outcomes in cancer versus benign cells.https://www.mdpi.com/2076-0817/11/5/493oncolytic virusparainfluenza viruscell killing
spellingShingle Kritika Kedarinath
Griffith D. Parks
Differential In Vitro Growth and Cell Killing of Cancer versus Benign Prostate Cells by Oncolytic Parainfluenza Virus
Pathogens
oncolytic virus
parainfluenza virus
cell killing
title Differential In Vitro Growth and Cell Killing of Cancer versus Benign Prostate Cells by Oncolytic Parainfluenza Virus
title_full Differential In Vitro Growth and Cell Killing of Cancer versus Benign Prostate Cells by Oncolytic Parainfluenza Virus
title_fullStr Differential In Vitro Growth and Cell Killing of Cancer versus Benign Prostate Cells by Oncolytic Parainfluenza Virus
title_full_unstemmed Differential In Vitro Growth and Cell Killing of Cancer versus Benign Prostate Cells by Oncolytic Parainfluenza Virus
title_short Differential In Vitro Growth and Cell Killing of Cancer versus Benign Prostate Cells by Oncolytic Parainfluenza Virus
title_sort differential in vitro growth and cell killing of cancer versus benign prostate cells by oncolytic parainfluenza virus
topic oncolytic virus
parainfluenza virus
cell killing
url https://www.mdpi.com/2076-0817/11/5/493
work_keys_str_mv AT kritikakedarinath differentialinvitrogrowthandcellkillingofcancerversusbenignprostatecellsbyoncolyticparainfluenzavirus
AT griffithdparks differentialinvitrogrowthandcellkillingofcancerversusbenignprostatecellsbyoncolyticparainfluenzavirus